Eating in the GLP-1 era: What’s worth the bite?

25 Sept 2026
Main Stage
Main Stage

As GLP‑1 treatments evolve and usage becomes more sustained - particularly through pill formats - appetite patterns are shifting permanently. Consumers are eating less, choosing differently, and becoming more selective about what food is worth eating at all. For CPGs, this changes the game. As portions shrink, the pressure on every bite increases. Food has to work harder, nutritionally and emotionally. So, what now earns a place in the basket? From protein to fibre, how should brands rethink formulation and portioning as consumer demand fundamentally resets?  

Host
Caroline Young
Caroline Young, Head of Insights
Speakers
Helen Bass
Helen Bass, VP Growth and Innovation
Mette Bhatia Frederiksen
Mette Bhatia Frederiksen, Global Head of F&D Applied R&D
Anne Widart
Anne Widart, Chief Commercial Officer